一種定量實時多聚酶鏈反應(yīng)(PCR)能夠快速準(zhǔn)確的診斷巨細(xì)胞病毒(CMV)，改善免疫抑制患者的治療。

Smart CMV檢測是由Cepheid公司(Sunnyvale, CA, USA)推出用于該公司SmartCycler系統(tǒng)臨床診斷用途。該檢測已經(jīng)獲得了歐洲體外診斷(IVD)醫(yī)療設(shè)備標(biāo)準(zhǔn)的CE標(biāo)記。設(shè)計用于CMV病毒負(fù)荷的快速檢測和定量，這種檢測方法能夠檢測感染但是沒有癥狀、潛伏期感染和再感染的患者。CMV是一種皰疹病毒，是諸如器官移植、艾滋病和癌癥等免疫抑制患者感染和死亡的重要原因。
 
PCR Assay Monitors CMV in Immunocompromised Patients
 
A quantitative real-time polymerase chain reaction (PCR) test provides rapid and accurate diagnosis of cytomegalovirus (CMV) and improved management of immunocompromised patients.

The Smart CMV assay was launched by Cepheid (Sunnyvale, CA, USA) for clinical diagnostic use on its SmartCycler system. The assay has received the CE mark under the European Directive for in vitro diagnostic (IVD) medical devices. Intended for rapid detection and quantitation of CMV viral load, the assay monitors patients for infections that can be asymptomatic and lead to latent infection and reinfection. CMV, which is a herpes virus, is a significant cause of infection and mortality among immunocompromised patients, such as organ transplant recipients andAIDS and cancer patients.